The immunosuppressant rapamycin can regulate the translation of a subset of messenger RNAs, a phenotype which has been linked to the presence of a polypyrimidine motif [C(N) 4-14 ] downstream of the mRNA cap structure. T-cell clones naturally infected with transcriptionally active human T-cell leukaemia virus, type I (HTLV-I) undergo autologous proliferation ; this phenotype is inhibited by rapamycin but not FK506, which reverses the rapamycin effect. Within the R region of the HTLV-I 5h long terminal repeat (LTR) there are seven polypyrimidine motifs. We sought to determine if these were involved in the sensitivity of proliferation to the presence of rapamycin. Here we illustrate the generation of an in vitro model of this rapamycin-sensitivity and the analysis of LTR mutants which were created to determine the importance of the polypyrimidine motifs. Reporter gene assays suggest the effect is independent of the polypyrimidine motifs in the virus leader sequence.
The immunosuppressant rapamycin can regulate the translation of a subset of messenger RNAs, a phenotype which has been linked to the presence of a polypyrimidine motif [C(N) 4-14 ] downstream of the mRNA cap structure. T-cell clones naturally infected with transcriptionally active human T-cell leukaemia virus, type I (HTLV-I) undergo autologous proliferation ; this phenotype is inhibited by rapamycin but not FK506, which reverses the rapamycin effect. Within the R region of the HTLV-I 5h long terminal repeat (LTR) there are seven polypyrimidine motifs. We sought to determine if these were involved in the sensitivity of proliferation to the presence of rapamycin. Here we illustrate the generation of an in vitro model of this rapamycin-sensitivity and the analysis of LTR mutants which were created to determine the importance of the polypyrimidine motifs. Reporter gene assays suggest the effect is independent of the polypyrimidine motifs in the virus leader sequence.
Human T-cell leukaemia virus type I (HTLV-I) is causatively associated with an aggressive malignancy, adult T-cell leukaemia (ATL), and the demyelinating disease HTLV-Iassociated myelopathy\tropical spastic paraparesis (HAM\ TSP). Peripheral blood mononuclear cells (PBMCs) from HAM\TSP-affected individuals demonstrate an abnormally high level of spontaneous proliferation in vitro. The production of primary T-cell clones from PBMCs derived from HAM\ TSP-infected individuals revealed the presence of uninfected and infected populations of cells. Of the cells which harbour an HTLV-I provirus some demonstrate a high level of proliferation in the absence of exogenous interleukin-2 (IL-2) whereas others do not (Ho$ llsberg et al., 1992) . This autonomous proliferation, which correlates with the presence of a transcriptionally active provirus (Ho$ llsberg et al., 1992) , is ILAuthor for correspondence : Nicola Rose.
Fax j44 1223 336846. e-mail njr1004!mole.bio.cam.ac.uk 2 and IL-2R independent (Wucherpfennig et al., 1992) , and may relate to the development of T-cell malignancy. The proliferating infected cells can also trigger proliferation in bystander cells in an IL-2-dependent manner (Wucherpfennig et al., 1992) , a mechanism which may be central to the development of HAM\TSP and other autoimmune diseases associated with HTLV-I infection.
Transcription of an HTLV-I provirus requires the viral trans-activating protein, Tax. Tax regulates transcription through indirect binding, via secondary proteins, to various motifs within the viral 5h long terminal repeat (LTR), most notably the binding of the cAMP-responsive element binding protein (CREB) to the 21 bp imperfect repeats in the U3 region (reviewed in Flint & Shenk, 1997) . In addition Tax is increasingly recognized as affecting the regulation of a number of cellular gene promoters (reviewed in Mesnard & Devaux, 1999) .
A striking feature of the T-cell clones is the selective inhibition of the autonomous proliferation by rapamycin (Ho$ llsberg et al., 1992) . This immunosuppressant (reviewed in has recently been shown to selectively suppress the mitogen-induced translation of a subset of mRNAs. The translation of most mRNAs remains unaffected (Terada et al., 1994 ; Nielsen et al., 1995 ; Mendez et al., 1996 ; Jeffries et al., 1997) . A feature of the affected mRNAs is the presence of a 5h-terminal oligopyrimidine tract (5h TOP) downstream of their N(-methylguanosine (m(G) cap structures. This motif is composed of between 5 and 15 nucleotides the first of which is invariably cytosine. It has been proposed that rapamycin binds a member of the FK506-binding protein family, FKBP-12, creating a complex which binds with the FKBP-12-rapamycin-associated protein (FRAP) kinase (reviewed in Brown & Schreiber, 1996) . Kinase activity is abrogated preventing phosphorylation, and hence activation, of eukaryotic initiation factor 4E (eIF4E)-binding protein, 4E-BP1 (Pause et al., 1994) . eIF4E possesses helicase activity : unphosphorylated 4E-BP1 sequesters free eIF4E forming an inactive complex thus preventing association of the elongation factor with mRNA cap structures. This coupling is essential for efficient translation as it is speculated that further initiation factors are subsequently attracted whose function is to assist unwinding of secondary structure in the 5huntranslated regions of mRNAs. This pathway is distinct from previously described Jak-Stat and Ras-MAP kinase pathways (Brown & Schreiber, 1996) .
Downstream of the U3 region lies the R region of the HTLV-I 5h LTR ; this region harbours six motifs conforming to 5h TOP structural constraints. The first has a thymine as the initial base but is in the most conserved position for a rapamycin effect ; the other five all begin with a cytosine. We investigated whether these motifs act as control elements for rapamycin-induced translational regulation through the use of LTR-and mutant LTR-chloramphenicol acetyltransferase (CAT) reporter plasmids. The first polypyrimidine motif of the wild-type, CR-CAT construct [the CAT gene driven by the HTLV-I 5h LTR (pU3R-I ; Sodroski et al., 1984) ; Fig. 1 ] was altered to a polypurine motif by site-directed mutagenesis (Kunkel et al., 1987) via a pBluescript KSII(j) (Stratagene) intermediate which harboured a 716 bp XhoI-HindIII LTRcontaining fragment from CR-CAT. The sequence of the antisense mutagenic oligonucleotide used was 5h GCCGGG-CGCGTCCTTCCTCCCTGCGAGCCCCCTC 3h. The CR-CAT R region deletion mutant [CR(∆R)-CAT ; Fig. 1 ] was generated by PCR mutagenesis using Pfu. DNA polymerase (Stratagene). Sequence flanking the region to be deleted from CR-CAT was amplified using the opposing oligonucleotides ∆Ra (5h CTCGCATCTCTCCTTCAggcctctgta 3h) and ∆Rs (5h gccccgataTCTGTTCTGCGCCGTTAC 3h) where sequences in uppercase are complementary to LTR sequence and those in italics introduce a StuI (∆Ra) or an EcoRV (∆Rs) restriction site. 10 µg CR-CAT DNA was amplified in a 100 µl reaction volume comprising 1inative reaction buffer (Stratagene), 4n5 mM MgCl # , 0n25 mM each dNTP, 0n12 µM each oligonucleotide and 0n02 units Pfu. DNA polymerase. A single incubation at 96 mC for 45 s was followed by 25 cycles comprising 96 mC for 45 s, 37 mC for 45 s and 72 mC for 10 min and an additional single extension step at 72 mC for 10 min. Gel-purified amplicon was restricted with the appropriate enzymes and circularized using a Rapid Ligase kit (Boehringer Mannheim). All plasmids were confirmed by sequencing.
To determine the effect of rapamycin on the three LTRs 1 µg or 2n5 µg of each plasmid was transiently co-transfected into a 5 cm or 10 cm diameter tissue culture dish of COS-1 cells, respectively, with pcDNA3Tax\Rex [HTLV-I Tax expression vector (Rose et al., 2000) ] using the DEAE-dextran method (Sambrook et al., 1989) . Transfected cells were grown in media [DMEM (Gibco-BRL) supplemented with 10 % foetal calf serum and 1 % penicillin-streptomycin] containing rapamycin (Sandoz) at a final concentration of 0, 0n1, 1, 10, 20 or 60 nM. The levels of CAT acetylation products in 5 µl supernatant were assessed 24 h post-transfection by thin-layer chromatography, quantified on an Instant Imager (Canberra Packard) and expressed as a percentage of that seen in the zero rapamycin control. The levels from all three were shown to decrease with increasing concentrations of rapamycin (Fig.  2 a) despite cell numbers remaining constant. Background expression levels of the plasmids were assessed in the absence of pcDNA3Tax\Rex and rapamycin in a duplicate experiment and were comparable to the negative Tris control (Fig.  2 b) . Results from four single transfections in which plasmids pES-CAT [the CAT gene under control of the human cytomegalovirus (CMV) immediate early promoter] and pIEP1-CAT (minimal CMV promoter sequences upstream of the CAT gene) were used are also shown (Fig. 2 a) . The lack of rapamycin-induced inhibition of CAT activity when the CMV-CAT constructs were substituted for CR-CAT indicates that the decrease in activity is LTR promoter-specific and not dependent on downstream coding regions. These results also indicate that the levels of CAT mRNA are unaffected by the presence of rapamycin as suggested by the unaltered levels of acetylated CAT protein in the CMV-CAT transfection experiments.
A similar rapamycin-dependent reduction in CR-CAT activity was seen compared to unchanged pIEP1-CAT-derived activity when these plasmids were transfected into Jurkat T cells (Fig. 2 c) as well as C8166-45 T cells (which generate Tax protein from integrated proviral sequences ; data not shown).
Transfection efficiency was assessed by transfection of plasmid CMV-GFP [green fluorescent protein (GFP) under control of the CMV promoter] into COS-1 cells in the presence and absence of rapamycin. The percentage of cells expressing GFP across the rapamycin concentration range was assessed following image capture on an Olympus IX70 fluorescent microscope using Image Pro Plus software. The ratio of GFPexpressing to non-expressing cells was calculated in three independent transfections and did not reflect the decrease of CAT activity seen across the same rapamycin concentration gradient (data not shown).
We investigated the HTLV-I-specific protein levels derived from cotransfected cells to confirm that Tax protein levels remained constant across the rapamycin concentration. Total cellular protein from 1i10' CR-CAT-transfected cells was harvested and 1\20 vol. blotted onto a nitrocellulose membrane using standard techniques. The primary detection antibody was a rabbit polyclonal antibody raised against the C terminus of Tax applied at a 1 : 400 dilution. The secondary, donkey anti-rabbit horseradish peroxidase-linked antibody (Amersham), was applied at a 1 : 1000 dilution. Proteins were detected using ECL reagents (Amersham), according to the manufacturer's instructions, followed by autoradiography. There was no significant decrease in Tax levels with increasing concentrations of rapamycin (data not shown). This indicates that the observed decrease in acetylated CAT products is not due to reduced levels of Tax protein available to activate the 5h LTR in the co-transfection experiments.
A further observation made with the T-cell clones was that, despite being sensitive to rapamycin, the autonomous proliferation was not affected by cyclosporin A or FK506 (tacrolimus). These immunosuppressants are usually able to prevent T-cell proliferation by interfering with IL-2 transcription (Sehgal, 1998) . We have shown that FK506 (Fujisawa GmbH, Munich, Germany) restores rapamycin-mediated abrogation of acetylation levels. Using plasmids CR-CAT and pcDNA3Tax\Rex in our reporter assay, transfected cells were grown in media containing (i) neither drug, (ii) 20 nM rapamycin, (iii) 40 µM FK506 or (iv) 20 nM rapamycin j40 µM FK506. Reporter gene activity was restored to nearwild-type levels when FK506 was present with rapamycin in the culture medium. FK506 alone had no suppressive effect on promoter activity as expected (Fig. 3) . This mirrors the effects witnessed in the T-cell clones (Ho$ llsberg et al., 1992) . FK506 and rapamycin show considerable structural similarity . It is likely that FK506 binds the same receptor as rapamycin competitively and is able to restore gene expression by displacing it. As these experiments utilized a large molar excess of FK506 over that of rapamycin it is likely that FK506 saturates the binding site thus preventing binding of rapamycin. Higher concentrations of rapamycin are required to inhibit FRAP activity in vitro than in vivo (Brown et al., 1995 ; Brunn et al., 1996 ; Chen et al., 1997 ; Scott et al., 1998) . It is therefore not unexpected that the required molar excess of FK506 over rapamycin in vitro might be larger than for the T-cell clones (Ho$ llsberg et al., 1992) . This observation is mirrored by the concentrations used in our study. The crystal structure of the ternary complex formed by rapamycin, FKBP-12 and the FRAP-binding domain (FRB) revealed that rapamycin binds to the hydrophobic regions of the two molecules drawing them together (Choi et al., 1996) . It is possible that the rapamycin-FKBP-12 complex has a greater affinity for FRAP than does FK506 ; thus abolition of the above association requires a high molar excess of FK506.
We have successfully generated a tissue culture model of the rapamycin-sensitive phenomenon of HTLV-I hereto observed solely in primary T-cells from HTLV-I-affected individuals. Several avenues of investigation were explored to determine the role of polypyrimidine tract motifs in the rapamycin-induced abrogation of HTLV-I promoter activity. We initially examined the cap structure-proximal motif by substituting the run of pyrimidines for purines which might be expected to cause loss of translational inhibition in vivo as has been noted for the ribosomal protein S16 transcript (Levy et al., 1991) ; however, no significant difference in response to the presence of rapamycin was observed. The equivalent effect in CR-CAT-transfected C8166-45 cells confirms the consistency of this phenomenon. From LTR mutant analysis we conclude that the R region of the HTLV-I 5h LTR does not possess sequences which are involved in rapamycin-sensitive translation pathways. Other proteins are known to interact with the viral 5h LTR by forming a complex with Tax protein which results in transcriptional activation ; thus a potential control point in this rapamycin-sensitive pathway may be the proteins with which Tax associates within the U3 region of the LTR such as CREB. Thus the effect of rapamycin, subverting the normal translational control of some mRNA species, manifests as a regulation of transcription in HTLV-I. In the absence of rapamycin-sensitive motifs within the LTR itself it is likely that the translation of one or more of these proteins may be affected by rapamycin thus indirectly affecting the transcription of HTLV-I. Current studies, employing U3 mutants, are aimed at identifying motifs in families of HTLV-I LTR-associated proteins. This rapamycin-sensitive pathway may be a potential therapeutic target in this and other retroviruses.
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